Link copied
Boston Scientific to buy Penumbra in $14.5 billion deal.
deals & business :: 2026-01-15 :: source - reuters
By Reuters
(Reuters) - Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline.
The deal values Penumbra at $374 per share, a premium of about 19.3% to its last close. Penumbra's shares rose 13% in premarket trading, while Boston's shares fell 2%.
The transaction is expected to be completed in 2026.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas)This week on Reuters
This week top market trends.
-
China to probe Meta's acquisition of artificial intelligence startup Manus
2026-01-08 :: companies :: apnews -
Yen tumbles on election bets, dollar still under pressure
2026-01-13 :: foreign exchange :: reuters -
Silver Soared by 144% in 2025. History Says This Could Happen in 2026
2026-01-08 :: investing ideas :: motley fool -
Japan’s Stock Market Has Strongest Start to the Year Since 1990
2026-01-06 :: stock :: bloomberg -
EU set to halt US trade deal over Trump’s new tariff threat
2026-01-18 :: watchlist :: bloomberg
Recent global market news
-
At an 11-Year Low with a 4.9% Dividend Yield, Is This Value Stock a No-Brainer Buy for Passive Income in 2026?
2026-01-12 :: :: motley fool -
As Trump Eyes Greenland, Smart Investors Should Watch These 2 Defense Stocks
2026-01-09 :: :: barchart
